Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability

References

• Schoemaker H, Claustre Y, Fage D, et al. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther. 1997;280:83–97.
   PubMed Web of Science ®Google Scholar
• Leucht S, Pitschel-Walz G, Engel RR, et al. Amisulpride, an unusual “atypical” antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry. 2002;159:180–190.
   PubMed Web of Science ®Google Scholar
• Schmitt U, Abou El-Ela A, Guo LJ, et al. Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). J Neural Transm. 2006;113:787–801.
   PubMed Web of Science ®Google Scholar
• El Ela AA, Hartter S, Schmitt U, et al. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds–implications for pharmacokinetics of selected substrates. J Pharm Pharmacol. 2004;56:967–975.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Pouton CW, Cuine JF, et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60:673–691.
   PubMed Web of Science ®Google Scholar
• Al-Mohizea A, Zawaneh F, Alam M, et al. Effect of pharmaceutical excipients on the permeability of P-glycoprotein substrate. J Drug Deliv Sci Technol. 2014;24:491–495.
   Web of Science ®Google Scholar
• Ghai D, Sinha VR. Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective beta(1)-adrenoreceptor blocker Talinolol. Nanomedicine 2012;8:618–626.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Katare O, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces. 2012;100:50–61.
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166–172.
   PubMed Web of Science ®Google Scholar
• Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380:133–141.
   PubMed Web of Science ®Google Scholar
• ElKasabgy NA. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability. Int J Pharm. 2014;460:33–44.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, et al. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2008;355:269–276.
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227–243.
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010;391:203–211.
   PubMed Web of Science ®Google Scholar
• Freag MS, Elnaggar YS, Abdallah OY. Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int J Nanomed. 2013;8:2385–2397.
   PubMed Web of Science ®Google Scholar
• Al-Mohizea AM. Influence of intestinal efflux pumps on the absorption and transport of furosemide. Saudi Pharm J. 2010;18:97–101.
   PubMedGoogle Scholar
• Devadasu C, Ravisankar P. Validated RP-HPLC method for the microgram determination of amisulpride in pure and pharmaceutical formulations. Int J Res Pharm Biomed Sci. 2011;2:202–211.
   Google Scholar
• Ruan L-P, Chen S, Yu B-Y, et al. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem. 2006;41:605–610.
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625–637.
   PubMed Web of Science ®Google Scholar
• Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 2009;10:69–76.
   PubMed Web of Science ®Google Scholar
• Chen M-L. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev. 2008;60:768–777.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun P, Nie S, et al. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm. 2005;31:785–794.
   PubMed Web of Science ®Google Scholar
• Nepal PR, Han H-K, Choi H-K. Preparation and in vitro–in vivo evaluation of Witepsol® H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q 10. Eur J Pharm Sci. 2010;39:224–232.
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release. 2004;98:427–436.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Li S-m, Mo F-k, et al. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006;321:117–123.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Gupta R, Saraf SA. PLGA nanoparticles of antitubercular drug: drug loading and release studies of a water in-soluble drug. Int J PharmTech Res. 2010;2:2116–2123.
   Google Scholar
• Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561–1572.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev. 2001;50:S127–S147.
   PubMed Web of Science ®Google Scholar
• Singh SK, Prasad Verma PR, Razdan B. Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization. Drug Dev Ind Pharm. 2010;36:933–945.
   PubMed Web of Science ®Google Scholar
• Sharma P, Chawla H, Panchagnula R. LC determination of cephalosporins in in vitro rat intestinal sac absorption model. J Pharm Biomed Anal. 2002;27:39–50.
   PubMed Web of Science ®Google Scholar
• Dixit P, Jain DK, Dumbwani J. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J Pharmacol Toxicol Methods. 2012;65:13–17.
   PubMed Web of Science ®Google Scholar